The Finasteride Riddle
January 2014
in “
ScholarWorks - University of Montana (University of Montana)
”
TLDR Finasteride reduces low-grade prostate cancer but may not be beneficial overall.
The Prostate Cancer Prevention Trial tested finasteride for reducing prostate cancer incidence and found it decreased low-grade prostate cancer but seemingly increased high-grade disease, leading to the FDA not approving it for chemoprevention. Follow-up data suggested concerns about finasteride's risks might have been unfounded, but it did not demonstrate a life-saving benefit. Although finasteride could potentially reduce overdiagnosis in PSA testing, other associated harms questioned its utility even in this secondary role.